新闻特写：美国昂贵的抗癌药物给医生和患者带来困扰。
News feature: Costly US anticancer drugs pose problems for doctors and patients.
作者信息
Charatan Fred
出版信息
BMJ. 2008 Jul 14;337(7662):a778. doi: 10.1136/bmj.a778.
Abstract
As the BMA calls for a royal commission to consider copayments for cancer drugs in the UK, looks at the problem in the US
摘要
英国医学协会呼吁成立一个皇家委员会来审议英国癌症药物的共付费用问题，美国则审视了这一问题。
相似文献
1
News feature: Costly US anticancer drugs pose problems for doctors and patients.新闻特写：美国昂贵的抗癌药物给医生和患者带来困扰。
BMJ. 2008 Jul 14;337(7662):a778. doi: 10.1136/bmj.a778.
2
Trastuzumab in breast cancer.曲妥珠单抗在乳腺癌中的应用
N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4.
3
Costly cancer drugs trigger proposals to modify clinical trial design.昂贵的癌症药物引发了修改临床试验设计的提议。
J Natl Cancer Inst. 2009 Dec 16;101(24):1662-4. doi: 10.1093/jnci/djp460.
4
Potential cost savings associated with dose rounding antineoplastic monoclonal agents.与抗肿瘤单克隆药物剂量舍入相关的潜在成本节约。
J Oncol Pharm Pract. 2015 Aug;21(4):280-4. doi: 10.1177/1078155214533369. Epub 2014 May 12.
5
Overspending driven by oversized single dose vials of cancer drugs.超大剂量单剂量瓶癌症药物导致的超支。
BMJ. 2016 Feb 29;352:i788. doi: 10.1136/bmj.i788.
6
Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.奖励价值创造以促进肿瘤学创新：考虑全球产品生命周期的重要性。
Oncologist. 2010;15 Suppl 1:49-57. doi: 10.1634/theoncologist.2010-S1-49.
7
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?辅助性乳腺癌曲妥珠单抗治疗所带来的巨大益处是否能抵消其高昂成本？
J Clin Oncol. 2007 Feb 20;25(6):611-3. doi: 10.1200/JCO.2006.09.3542.
8
How much will Herceptin really cost?赫赛汀的实际费用会是多少？
BMJ. 2006 Nov 25;333(7578):1118-20. doi: 10.1136/bmj.39008.624051.BE.
9
The costs of caring: Who pays? Who profits? Who panders?护理的成本：谁来支付？谁获利？谁迎合？
Hastings Cent Rep. 2006 May-Jun;36(3):13-7. doi: 10.1353/hcr.2006.0040.
10
GlaxoSmithKline cancer drug threatens Herceptin market.葛兰素史克公司的抗癌药物威胁到赫赛汀的市场。
Nat Biotechnol. 2005 Dec;23(12):1453-4. doi: 10.1038/nbt1205-1453.
引用本文的文献
1
Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?贝伐单抗用于治疗年龄相关性黄斑变性的超说明书用药：证据是什么？
Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002.
Zotero 插件